Clinical Trial Update: Disrupt CAD III With the Shockwave Coronary IVL System [NA]

View source ↗

Summary

Completed clinical trial of the Shockwave Coronary IVL System (Disrupt CAD III) with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• Shockwave Coronary Intravascular Lithotripsy System (intravascular lithotripsy)

Snippet

Sponsor: Shockwave Medical, Inc. | Conditions: Coronary Artery Disease, Myocardial Infarction | NA | Status: COMPLETED | Results posted: 2021-06-21